↓ Skip to main content

Spotlight on Subcutaneous Recombinant Interferon-β-1a (Rebif®) in Relapsing-Remitting Multiple Sclerosis

Overview of attention for article published in BioDrugs, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

patent
4 patents
wikipedia
14 Wikipedia pages

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
32 Mendeley